Claim OwnershipThe Academy Exchange: HIV Today & Tomorrow
Subscribed: 7Played: 36
Subscribe
© 2023 American Academy of HIV Medicine
Description
In the Academy Exchange, we discuss the latest advances in HIV prevention, care and treatment as well as examine the societal and systemic issues facing people with and at risk for HIV. Brought to you by the American Academy of HIV Medicine and its Executive Director, Bruce Packett, this series of interviews with clinical, research, epidemiological, public health and advocacy experts will demystify the current HIV landscape and point towards future developments. To learn more about the Academy, visit: https://aahivm.org.
13 Episodes
Reverse
Bruce is joined by Dr. Daniel Lee, who discuss HIV-associated weight changes – both gaining and losing weight. First, they examine weight gain in those with HIV and how it can accelerate aging as well as contribute to other diseases, such as hypertension and diabetes. They also discuss losing weight with HIV, although HIV-related weight loss is not as common today as it was in the early days of the HIV epidemic. They emphasize the importance of a healthy diet and maintaining physical activity...
Dr. Donna Sweet and Bruce discuss the history of the HIV epidemic through the lens of Dr. Sweet’s personal experience as a practitioner. They talk about the early experiences of treating and managing HIV and AIDS before tests, empirical treatments, and sufficient knowledge about the virus. They discuss how antiretroviral therapy and new clinical case definitions in the 1990s and 2000s allowed for better treatment and management of HIV. Throughout the conversation, they mention how the stigma ...
Dr. Milena Murray joins Bruce to discuss the implications of aging and HIV. Since nearly half of Americans living with HIV are over the age of 55, it is important to recognize their unique care needs as well as the risk of HIV in people over 55 generally. Bruce and Dr. Murray talk about the use of PrEP and how people can approach sexual health discussions with their providers. They also talk about what to expect with the use of antiretroviral therapies in conjunction with other medications pe...
Bruce is joined by Dr. Hannan Braun to talk about substance use disorder and its overlap with the HIV epidemic. They discuss what a substance use disorder is and the risks of HIV for those who inject illicit substances. They also cover the HIV pre-exposure prophylaxis (PrEP) that is available for those who have a substance use disorder and the benefits for using PrEP. As well, Dr. Braun covers the various options available for treating a substance use disorder and highlights the ways people c...
Dr. Heather Quaile joins Bruce to talk about trauma-informed care (TIC) and why it’s important for people to receive TIC whenever they visit a health care provider. A TIC approach means that providers understand the implications of traumatic events on patients and work to create a safe and supportive environment for all patients. This episode covers the ways that promoting a culture of trust and collaboration between providers and patients is a foundation for improving patient health. Not onl...
Bruce is joined by Angela Kapalko, PA-C, AAHIVS, to talk about the current state of the HIV Workforce and the needs of the future. As the generation of providers who started treating HIV at the beginning of the epidemic approach retirement, the need for a new generation of clinicians to care for the now aging population of people with HIV is greater than ever. Bruce and Angela discuss current trends and needs in the HIV workforce, specifically with regards to Nurse Practitioners a...
In the first episode of our second season you can learn about transgender and gender diverse care from a health care provider’s perspective. Dr. Michelle Collins-Ogle joins Bruce to discuss her experience providing gender affirming care to her transgender and gender diverse patients. They talk about what makes up gender-affirming care, the misconceptions around it, what it isn’t, and all the ways it can be applied in a health care setting. As well, they cover the ways that being transgender c...
Dr. Richard Silvera joins Bruce to discuss Mpox and Meningococcus and how the lessons learned from HIV outbreak response are applicable to these infectious diseases. They discuss the epidemiology of Mpox and meningococcus disease and the nuances between sexually transmitted infections and those spread by intimate contact. With the public being more aware of the importance of vaccines, it’s important to understand how healthcare providers can best respond to outbreaks of Mpox and meningococcus...
Heterosexual women are not the typical demographic that is targeted in HIV research and treatments. But their risk factors for HIV are different and require unique methods to address. Bruce and clinical HIV Specialist™ Dr. William R. Short discuss the needs of women and HIV with a focus on women who are pregnant or may become pregnant. For more information about the Antiretroviral Pregnancy Registry, visit http://www.apregistry.com/.About Dr. Short:...
Pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) are potential game changers in efforts to reduce the prevalence of HIV across the globe. But uptake continues to be lackluster, especially in traditionally underserved populations. Bruce and clinical HIV Pharmacist™ Dr. Carly Floyd discuss how PrEP has evolved over the last decade in clinical use for HIV prevention and share strategies for increasing PrEP and PEP access and uptake to populations that have not yet ...
Academy Executive Director, Bruce Packett, is joined by clinical HIV Pharmacist™ Dr. Brooke Stevens to discuss new and novel antiretroviral therapies including single pill regimens and long-acting injectables. These new regimens allow antiretroviral therapy to be administered less frequently, making it potentially easier for patients to remain adherent.They discuss who might be good candidates to consider switching to novel formulations and modalities, as well as trends in which patients are ...
Bruce is joined by clinical HIV Pharmacist™ Dr. Brooke Stevens to discuss new and novel antiretroviral therapies including single pill regimens and long-acting injectables. These new regimens allow antiretroviral therapy to be administered less frequently, making it potentially easier for patients to remain adherent.Enjoy this teaser of episode 1 of the Academy Exchange: HIV Today & Tomorrow! Subscribe to hear full episodes as they are released!
Bonus Episode: IAS 2023 Conference HighlightsDr. William Short and Dr. Laura Armas-Kolostroubis join Bruce to talk about the research coming out of the 12th IAS Conference on HIV Science that took place July 23-26, 2023. They discuss some of the groundbreaking studies presented at the conference and how the research can be translated into clinical practice. They talk about research on zero transmission, studies looking at the next steps in long-acting technologies, and findings from a clinica...
Comments
Download from Google Play
Download from App Store
United States